Skip to content
10-Q

Quarterly Report

Connect Biopharma Holdings Ltd CNTB

0001835268-25-000052

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 55.72M sh
Shares Diluted Q2 2025 · Jun 30, 2025 55.5M sh
Shares Diluted Q2 2025 · Jun 30, 2025 55.43M sh
Shares Diluted Q2 2025 · Jun 30, 2024 55.71M sh
Shares Diluted Q2 2025 · Jun 30, 2024 55.55M sh
Capex Q2 2025 · Jun 30, 2025 $384K
Capex Q2 2025 · Jun 30, 2024 $290K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$22.55M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$8.29M
Short Term Investments Q2 2025 · Jun 30, 2025 $31.14M
Short Term Investments Q2 2025 · Dec 31, 2024 $15.48M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $40.63M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $78.23M
Stockholders Equity Q2 2025 · Jun 30, 2025 $71.34M
Stockholders Equity Q2 2025 · Mar 31, 2025 $82.9M
Stockholders Equity Q2 2025 · Dec 31, 2024 $92.17M
Stockholders Equity Q2 2025 · Jun 30, 2024 $110.93M
Stockholders Equity Q2 2025 · Mar 31, 2024 $93.9M
Stockholders Equity Q2 2025 · Dec 31, 2023 $101.5M
Current Liabilities Q2 2025 · Jun 30, 2025 $10.74M
Current Liabilities Q2 2025 · Dec 31, 2024 $8.46M
Total Liabilities Q2 2025 · Jun 30, 2025 $11.38M
Total Liabilities Q2 2025 · Dec 31, 2024 $9.12M
Current Assets Q2 2025 · Jun 30, 2025 $77.76M
Current Assets Q2 2025 · Dec 31, 2024 $96.96M
Total Assets Q2 2025 · Jun 30, 2025 $82.73M
Total Assets Q2 2025 · Dec 31, 2024 $101.28M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.23
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.42
Eps Diluted Q2 2025 · Jun 30, 2024 $0.27
Eps Diluted Q2 2025 · Jun 30, 2024 $0.11
Eps Basic Q2 2025 · Jun 30, 2025 −$0.23
Eps Basic Q2 2025 · Jun 30, 2025 −$0.42
Eps Basic Q2 2025 · Jun 30, 2024 $0.27
Eps Basic Q2 2025 · Jun 30, 2024 $0.11
Sga Expense Q2 2025 · Jun 30, 2025 $4.7M
Sga Expense Q2 2025 · Jun 30, 2025 $9.51M
Sga Expense Q2 2025 · Jun 30, 2024 $5.12M
Sga Expense Q2 2025 · Jun 30, 2024 $9.09M
Rd Expense Q2 2025 · Jun 30, 2025 $8.77M
Rd Expense Q2 2025 · Jun 30, 2025 $15.41M
Rd Expense Q2 2025 · Jun 30, 2024 $5.35M
Rd Expense Q2 2025 · Jun 30, 2024 $14.01M
Net Income Q2 2025 · Jun 30, 2025 −$12.9M
Net Income Q2 2025 · Jun 30, 2025 −$23.17M
Net Income Q2 2025 · Mar 31, 2025 −$10.27M
Net Income Q2 2025 · Jun 30, 2024 $14.85M
Net Income Q2 2025 · Jun 30, 2024 $6.15M
Net Income Q2 2025 · Mar 31, 2024 −$8.69M
Operating Income Q2 2025 · Jun 30, 2025 −$13.42M
Operating Income Q2 2025 · Jun 30, 2025 −$24.87M
Operating Income Q2 2025 · Jun 30, 2024 $13.65M
Operating Income Q2 2025 · Jun 30, 2024 $1.01M
Revenue Q2 2025 · Jun 30, 2025 $48K
Revenue Q2 2025 · Jun 30, 2025 $48K
Revenue Q2 2025 · Jun 30, 2024 $24.12M
Revenue Q2 2025 · Jun 30, 2024 $24.12M